TrialsgrambetaRCTs are beautiful

CONVINCE

2023

Comparison of High-Dose Haemodiafiltration with High-Flux Haemodialysis

In 1,360 prevalent haemodialysis patients, high-dose haemodiafiltration reduced all-cause mortality compared with conventional high-flux haemodialysis.

Result

Efficacy: All-cause mortalityHR 0.77 (95% CI 0.65-0.93)

Below 1 favours high-dose haemodiafiltration, above 1 favours conventional high-flux haemodialysis.

Event rates
Absolute difference
4.6 points
NNT
22

Absolute difference and NNT are derived from the event rates.

Original publication
Subtopic
Haemodiafiltration
Design
International open-label RCT, median 30-month follow-up
Relevance
Important: one of several pillars.
Source
Blankestijn PJ, et al. N Engl J Med. 2023;389(8):700-709.doi 10.1056/NEJMoa2304820

Discussion & critique

First clearly positive haemodiafiltration mortality trial; a relatively healthy European cohort limits generalisability.

Discussed in podcasts